| 臺大學術典藏 |
2022-01-12T07:07:10Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; HSIN-AN HOU; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
|
Wang Y.-H.; HSIN-AN HOU; Lin C.-C.; Kuo Y.-Y.; Yao C.-Y.; Hsu C.-L.; Tseng M.-H.; Tsai C.-H.; Peng Y.-L.; Kao C.-J.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2021-07-28T03:10:02Z |
Application of non-invasive low-intensity pulsed electric field with thermal cyclinghyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells
|
Lu, C.-H.;Kuo, Y.-Y.;Lin, G.-B.;Chen, W.-T.;Chao, C.-Y.; Lu, C.-H.; Kuo, Y.-Y.; Lin, G.-B.; Chen, W.-T.; Chao, C.-Y.; CHIH-YU CHAO |
| 臺大學術典藏 |
2021-07-22T03:35:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; LIU JIA-HAU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:27Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
TIEN FENG-MING; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:27Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
TIEN FENG-MING; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
TIEN FENG-MING; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:26Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; TIEN FENG-MING; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; TIEN FENG-MING; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:22Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; TIEN FENG-MING; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou H.-A.; LIN YUN-CHU; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:29Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; LIN YUN-CHU; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-20T02:10:47Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
CHEN YIN-KAI; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-20T02:10:47Z |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
|
Kuo Y.-Y.; Hou H.-A.; CHEN YIN-KAI; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2021-06-28T06:52:23Z |
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
|
Lin C.-C.; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; Hou H.-A.; KENG-HSUEH LAN; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-31T07:54:21Z |
GATA-1 and NF-Y cooperate to mediate erythroid-specific transcription of Gfi-1B gene
|
Huang D.-Y.; Kuo Y.-Y.; Lai J.-S.; Suzuki Y.; Sugano S.; ZEE-FEN CHANG |
| 臺大學術典藏 |
2021-05-31T07:54:20Z |
GATA-1 mediates auto-regulation of Gfi-1B transcription in K562 cells
|
Huang D.-Y.; Kuo Y.-Y.; ZEE-FEN CHANG |
| 臺大學術典藏 |
2021-05-31T07:54:20Z |
Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability
|
Ke P.-Y.; Kuo Y.-Y.; Hu C.-M.; ZEE-FEN CHANG |
| 臺大學術典藏 |
2021-05-31T07:54:19Z |
GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription
|
Kuo Y.-Y.; ZEE-FEN CHANG |
| 臺大學術典藏 |
2021-05-31T07:54:12Z |
Epigenetic repression of ribosomal RNA transcription by ROCK-dependent aberrant cytoskeletal organization
|
Wu T.-H.; Kuo Y.-Y.; Lee H.-H.; Kuo J.-C.; Ou M.-H.; ZEE-FEN CHANG |
| 臺大學術典藏 |
2021-05-26T09:08:21Z |
Characterization of acute myeloid leukemia with MLL rearrangements - No increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts
|
Tien H.-F.; Hsiao C.-H.; Tang J.-L.; Tsay W.; Hu C.-H.; Kuo Y.-Y.; Wang C.-H.; YAO-CHANG CHEN; Shen M.-C.; Lin D.-T.; Lin K.-H.; Lin K.-S. |
| 臺大學術典藏 |
2021-05-26T09:08:19Z |
Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23
|
Shiah H.-S.; Kuo Y.-Y.; Tang J.-L.; Huang S.-Y.; Yao M.; Tsay W.; YAO-CHANG CHEN; Wang D.-T. C.-H. -au Shen, Lin K.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-26T09:08:02Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; YAO-CHANG CHEN; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-26T09:08:01Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; YAO-CHANG CHEN; Tien H.-F. |
